Published in J Clin Invest on September 01, 1999
A GRK5 polymorphism that inhibits beta-adrenergic receptor signaling is protective in heart failure. Nat Med (2008) 3.98
Inhibition of endogenous thioredoxin in the heart increases oxidative stress and cardiac hypertrophy. J Clin Invest (2003) 2.19
Cardiac beta ARK1 inhibition prolongs survival and augments beta blocker therapy in a mouse model of severe heart failure. Proc Natl Acad Sci U S A (2001) 1.97
Meeting Koch's postulates for calcium signaling in cardiac hypertrophy. J Clin Invest (2000) 1.79
Disruption of type 5 adenylyl cyclase gene preserves cardiac function against pressure overload. Proc Natl Acad Sci U S A (2003) 1.64
The MEKK1-JNK pathway plays a protective role in pressure overload but does not mediate cardiac hypertrophy. J Clin Invest (2002) 1.56
Beta-adrenergic stimulation and myocardial function in the failing heart. Heart Fail Rev (2009) 1.40
Modulation of beta-adrenergic receptor signaling in heart failure and longevity: targeting adenylyl cyclase type 5. Heart Fail Rev (2010) 1.24
Developmental effects of chlorpyrifos extend beyond neurotoxicity: critical periods for immediate and delayed-onset effects on cardiac and hepatic cell signaling. Environ Health Perspect (2004) 1.20
Inhibition of p38 alpha MAPK rescues cardiomyopathy induced by overexpressed beta 2-adrenergic receptor, but not beta 1-adrenergic receptor. J Clin Invest (2007) 1.17
Borrelia burgdorferi intercepts host hormonal signals to regulate expression of outer surface protein A. Proc Natl Acad Sci U S A (2007) 0.97
Programmed cell death in cardiac myocytes: strategies to maximize post-ischemic salvage. Heart Fail Rev (2008) 0.94
β1-Adrenergic receptor blockade extends the life span of Drosophila and long-lived mice. Age (Dordr) (2013) 0.90
Epac1-dependent phospholamban phosphorylation mediates the cardiac response to stresses. J Clin Invest (2014) 0.89
β-Adrenergic receptor stimulation and activation of protein kinase A protect against α1-adrenergic-mediated phosphorylation of protein kinase D and histone deacetylase 5. J Card Fail (2011) 0.85
Akt2 deficiency promotes cardiac induction of Rab4a and myocardial β-adrenergic hypersensitivity. J Mol Cell Cardiol (2010) 0.84
Adenylyl cyclase type 5 in cardiac disease, metabolism, and aging. Am J Physiol Heart Circ Physiol (2013) 0.83
Differential expression of Gs in a murine model of homocysteinemic heart failure. Vasc Health Risk Manag (2009) 0.82
Propranolol enhances cell cycle-related gene expression in pressure overloaded hearts. Br J Pharmacol (2011) 0.79
Cardiomyocyte life-death decisions in response to chronic β-adrenergic signaling. Circ Res (2013) 0.79
GNAS gene variants affect β-blocker-related survival after coronary artery bypass grafting. Anesthesiology (2014) 0.79
Progressive loss of creatine maintains a near normal DeltaG approximately (ATP) in transgenic mouse hearts with cardiomyopathy caused by overexpressing Gsalpha. J Mol Cell Cardiol (2009) 0.78
Renal Denervation: A Potential Novel Treatment for Type 2 Diabetes Mellitus? Medicine (Baltimore) (2015) 0.77
Effects of GRK5 and ADRB1 polymorphisms influence on systolic heart failure. J Transl Med (2015) 0.77
Regulator of G Protein Signaling 6 Protects the Heart from Ischemic Injury. J Pharmacol Exp Ther (2016) 0.75
AT1 receptor antagonism to reduce aortic expansion in Marfan syndrome: lost in translation or in need of different interpretation? Arterioscler Thromb Vasc Biol (2014) 0.75
Effects of anesthesia on conventional and speckle tracking echocardiographic parameters in a mouse model of pressure overload. Exp Ther Med (2015) 0.75
Cardiac Effects of Attenuating Gsα - Dependent Signaling. PLoS One (2016) 0.75
The effect of carvedilol on morbidity and mortality in patients with chronic heart failure. U.S. Carvedilol Heart Failure Study Group. N Engl J Med (1996) 12.77
The Cardiac Insufficiency Bisoprolol Study II (CIBIS-II): a randomised trial. Lancet (1999) 11.26
Apoptosis in the failing human heart. N Engl J Med (1997) 6.35
Apoptosis in myocytes in end-stage heart failure. N Engl J Med (1996) 6.19
Enhanced myocardial function in transgenic mice overexpressing the beta 2-adrenergic receptor. Science (1994) 4.84
MLP-deficient mice exhibit a disruption of cardiac cytoarchitectural organization, dilated cardiomyopathy, and heart failure. Cell (1997) 4.67
Cardiac function in mice overexpressing the beta-adrenergic receptor kinase or a beta ARK inhibitor. Science (1995) 4.18
Progressive hypertrophy and heart failure in beta1-adrenergic receptor transgenic mice. Proc Natl Acad Sci U S A (1999) 3.13
Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 2.91
Norepinephrine stimulates apoptosis in adult rat ventricular myocytes by activation of the beta-adrenergic pathway. Circulation (1998) 2.91
A randomized trial of beta-blockade in heart failure. The Cardiac Insufficiency Bisoprolol Study (CIBIS). CIBIS Investigators and Committees. Circulation (1994) 2.58
Clinical effects of beta-adrenergic blockade in chronic heart failure: a meta-analysis of double-blind, placebo-controlled, randomized trials. Circulation (1998) 2.35
Targeted overexpression of protein kinase C beta2 isoform in myocardium causes cardiomyopathy. Proc Natl Acad Sci U S A (1997) 2.02
Targeted disruption of the mouse beta1-adrenergic receptor gene: developmental and cardiovascular effects. Proc Natl Acad Sci U S A (1996) 2.02
Dilated cardiomyopathy in transgenic mice expressing a dominant-negative CREB transcription factor in the heart. J Clin Invest (1998) 2.00
Stretch-induced programmed myocyte cell death. J Clin Invest (1995) 1.99
Overexpression of angiotensin AT1 receptor transgene in the mouse myocardium produces a lethal phenotype associated with myocyte hyperplasia and heart block. Proc Natl Acad Sci U S A (1997) 1.78
beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ Res (1997) 1.73
Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res (1996) 1.65
Apoptosis in pressure overload-induced heart hypertrophy in the rat. J Clin Invest (1996) 1.65
Cardiac-specific overexpression of mouse cardiac calsequestrin is associated with depressed cardiovascular function and hypertrophy in transgenic mice. J Biol Chem (1998) 1.60
Myofibril degeneration caused by tropomodulin overexpression leads to dilated cardiomyopathy in juvenile mice. J Clin Invest (1998) 1.59
Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest (1995) 1.50
beta-adrenergic stimulation causes cardiocyte apoptosis: influence of tachycardia and hypertrophy. Am J Physiol (1998) 1.35
Apoptosis of cardiac myocytes in Gsalpha transgenic mice. Circ Res (1999) 1.28
Cardiac compartment-specific overexpression of a modified retinoic acid receptor produces dilated cardiomyopathy and congestive heart failure in transgenic mice. J Clin Invest (1997) 1.23
Cardiomyopathy induced by cardiac Gs alpha overexpression. Am J Physiol (1997) 1.22
Magnetic resonance imaging and invasive evaluation of development of heart failure in transgenic mice with myocardial expression of tumor necrosis factor-alpha. Circulation (1999) 1.09
Myocyte nuclear mitotic division and programmed myocyte cell death characterize the cardiac myopathy induced by rapid ventricular pacing in dogs. Lab Invest (1995) 1.02
Hemodynamic mechanisms responsible for reduced subendocardial coronary reserve in dogs with severe left ventricular hypertrophy. Circulation (1995) 1.01
Depressed heart rate variability and arterial baroreflex in conscious transgenic mice with overexpression of cardiac Gsalpha. Circ Res (1998) 1.01
Cardiomyopathy in transgenic myf5 mice. Circ Res (1996) 0.95
Differential regulation of inotropy and lusitropy in overexpressed Gsalpha myocytes through cAMP and Ca2+ channel pathways. J Clin Invest (1999) 0.90
Effects of adrenergic receptor antagonists on cardiac morphological and functional alterations in rats harboring pheochromocytoma. J Pharmacol Exp Ther (1987) 0.88
Life and death in the cardiovascular system. Circulation (1997) 0.87
Overexpression of myocardial Gsalpha prevents full expression of catecholamine desensitization despite increased beta-adrenergic receptor kinase. J Clin Invest (1998) 0.84
Carvedilol prevents severe hypertensive cardiomyopathy and remodeling. J Hypertens (1998) 0.83
Effect of long-term treatment with beta-blocker on cardiac hypertrophy in SHR. J Mol Cell Cardiol (1989) 0.81
Comparative efficacy of a DA2/alpha2 agonist and a beta-blocker in reducing adrenergic drive and cardiac fibrosis in an experimental model of left ventricular dysfunction after coronary artery occlusion. J Cardiovasc Pharmacol (1998) 0.81
Myocyte apoptosis and heart failure. Eur Heart J (1998) 0.81
Psychosocial treatments for cocaine dependence: National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Arch Gen Psychiatry (1999) 4.22
Array-based genomic resequencing of human leukemia. Oncogene (2010) 3.77
Oral contraceptives and the risk of hereditary ovarian cancer. Hereditary Ovarian Cancer Clinical Study Group. N Engl J Med (1998) 3.60
A mammalian model for Laron syndrome produced by targeted disruption of the mouse growth hormone receptor/binding protein gene (the Laron mouse). Proc Natl Acad Sci U S A (1997) 3.42
The efficacy of cognitive therapy in depression: a treatment trial using cognitive therapy and pharmacotherapy, each alone and in combination. Br J Psychiatry (1981) 3.37
The Modified Hamilton Rating Scale for Depression: reliability and validity. Psychiatry Res (1985) 3.13
Environmental factors influencing the production of fusarenon-X, a cytotoxic mycotoxin of Fusarium nivale Fn 2B. Chem Pharm Bull (Tokyo) (1970) 3.10
Use of antibody-coated red cells for the sensitive detection of antigen and in rosette tests for cells bearing surface immunoglobulins. J Immunol Methods (1977) 2.97
Excess of rare cancers in Werner syndrome (adult progeria). Cancer Epidemiol Biomarkers Prev (1996) 2.76
Microinjection of a rabbit beta-globin gene into zygotes and its subsequent expression in adult mice and their offspring. Proc Natl Acad Sci U S A (1981) 2.74
Hibernating myocardium. N Engl J Med (1998) 2.72
Macrophages and atherosclerotic plaque stability. Curr Opin Lipidol (1996) 2.68
Expression of cyr61, a growth factor-inducible immediate-early gene. Mol Cell Biol (1990) 2.64
Regional myocardial functional and electrophysiological alterations after brief coronary artery occlusion in conscious dogs. J Clin Invest (1975) 2.58
Protecting severely abused and neglected children. An unkept promise. N Engl J Med (1990) 2.58
Cyr61, a product of a growth factor-inducible immediate-early gene, promotes cell proliferation, migration, and adhesion. Mol Cell Biol (1996) 2.44
Molecular mechanism of interleukin-8 gene expression. J Leukoc Biol (1994) 2.35
Overexpression of insulin-like growth factor-1 in the heart is coupled with myocyte proliferation in transgenic mice. Proc Natl Acad Sci U S A (1996) 2.34
Prevention of pulmonary morbidity for patients with Duchenne muscular dystrophy. Chest (1997) 2.19
Polymorphism in RANTES chemokine promoter affects HIV-1 disease progression. Proc Natl Acad Sci U S A (1999) 2.17
An interspecific comparison of foraging range and nest density of four bumblebee (Bombus) species. Mol Ecol (2005) 2.04
Novel mechanism of glucocorticoid-mediated gene repression. Nuclear factor-kappa B is target for glucocorticoid-mediated interleukin 8 gene repression. J Biol Chem (1994) 2.02
Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation (1999) 1.97
Chelerythrine rapidly induces apoptosis through generation of reactive oxygen species in cardiac myocytes. J Mol Cell Cardiol (2001) 1.97
Insertion of a 5' truncated L1 element into the 3' end of exon 44 of the dystrophin gene resulted in skipping of the exon during splicing in a case of Duchenne muscular dystrophy. J Clin Invest (1993) 1.92
The Akt-glycogen synthase kinase 3beta pathway regulates transcription of atrial natriuretic factor induced by beta-adrenergic receptor stimulation in cardiac myocytes. J Biol Chem (2000) 1.92
Toxicological approaches to the metabolites of Fusaria. II. Isolation of fusarenon-X from the culture filtrate of Fusarium nivale Fn 2B. Jpn J Exp Med (1971) 1.88
Cyr61 and Fisp12 are both ECM-associated signaling molecules: activities, metabolism, and localization during development. Exp Cell Res (1997) 1.88
Glycogen synthase kinase 3beta regulates GATA4 in cardiac myocytes. J Biol Chem (2001) 1.87
A two-year naturalistic follow-up of depressed patients treated with cognitive therapy, pharmacotherapy and a combination of both. J Affect Disord (1986) 1.86
Inhibitory effects of mycotoxins on the protein synthesis in rabbit reticulocytes. J Biochem (1969) 1.83
Cardiovascular control mechanisms in the conscious state. N Engl J Med (1975) 1.82
Extraordinarily polymorphic microsatellite DNA in barley: species diversity, chromosomal locations, and population dynamics. Proc Natl Acad Sci U S A (1994) 1.77
beta-Arrestin1 knockout mice appear normal but demonstrate altered cardiac responses to beta-adrenergic stimulation. Circ Res (1997) 1.73
Expression, function, and clinical implications of the estrogen receptor beta in human lung cancers. Biochem Biophys Res Commun (2001) 1.67
Caveolin is an activator of insulin receptor signaling. J Biol Chem (1998) 1.66
Caveolin interaction with protein kinase C. Isoenzyme-dependent regulation of kinase activity by the caveolin scaffolding domain peptide. J Biol Chem (1997) 1.66
Adverse effects of chronic endogenous sympathetic drive induced by cardiac GS alpha overexpression. Circ Res (1996) 1.65
Toxicological approaches to the metabolites of Fusaria. I. Screening of toxic strains. Jpn J Exp Med (1971) 1.64
The effects of a myocardial bridge on coronary atherosclerosis and ischaemia. J Pathol (1998) 1.62
Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway. Oncogene (2008) 1.59
Cyclosporine attenuates pressure-overload hypertrophy in mice while enhancing susceptibility to decompensation and heart failure. Circ Res (1999) 1.58
Comparative study on skin-necrotizing effect of scirpene metabolites of Fusaria. Jpn J Exp Med (1970) 1.57
The National Institute on Drug Abuse Collaborative Cocaine Treatment Study. Rationale and methods. Arch Gen Psychiatry (1997) 1.56
Modulation of immunoglobulin (Ig)E-mediated systemic anaphylaxis by low-affinity Fc receptors for IgG. J Exp Med (1999) 1.56
Bone metastasis and poor performance status are prognostic factors for survival of carcinoma of unknown primary site in patients treated with systematic chemotherapy. Ann Oncol (2009) 1.54
Overexpression of Gs alpha protein in the hearts of transgenic mice. J Clin Invest (1995) 1.50
Suppression of tumor necrosis factor-alpha production and neutrophil infiltration during ischemia-reperfusion injury of the liver after heat shock preconditioning. J Hepatol (2001) 1.50
Correlation between progression of spinal deformity and pulmonary function in Duchenne muscular dystrophy. J Pediatr Orthop (2001) 1.50
Effects of anaesthesia and recent surgery on diastolic function. Cardiovasc Res (1994) 1.49
Myocardial beta-adrenergic receptor function during the development of pacing-induced heart failure. J Clin Invest (1993) 1.46
Parasympathetic control of the heart. Pharmacol Rev (1973) 1.46
Adaptations of the left ventricle to chronic pressure overload. Circ Res (1976) 1.44
Effects of angiotensin, vasopressin, and methoxamine on cardiac function and blood flow distribution in conscious dogs. Am J Physiol (1976) 1.42
A female carrier of Duchenne muscular dystrophy complicated with cardiomyopathy. Intern Med (2000) 1.42
Expression of transforming growth factor-alpha in the normal cervix and in benign and malignant lesions of the uterine cervix. Br J Obstet Gynaecol (1994) 1.42
Effects of preconceptional irradiation on mortality and cancer incidence in the offspring of patients given injections of Thorotrast. J Natl Cancer Inst (1994) 1.42
Left ventricular response to severe exertion in untethered dogs. J Clin Invest (1972) 1.41
Earlobe crease and atherosclerosis. An autopsy study. J Am Geriatr Soc (1990) 1.41
Simultaneous comparison and calibration of the Doppler and electromagnetic flowmeters. J Appl Physiol (1970) 1.40
Portal and mesenteric venous thrombosis as a complication of endoscopic sclerotherapy. Am J Gastroenterol (1989) 1.39
Elective use of cannula cricothyroidotomy. Anaesthesia (2011) 1.39
Metabolic effects of developmental, tissue-, and cell-specific expression of a chimeric phosphoenolpyruvate carboxykinase (GTP)/bovine growth hormone gene in transgenic mice. J Biol Chem (1990) 1.39
Analysis of human V alpha 24+ CD4+ NKT cells activated by alpha-glycosylceramide-pulsed monocyte-derived dendritic cells. J Immunol (2000) 1.38
Isolation and characterization of a novel cardiac adenylylcyclase cDNA. J Biol Chem (1992) 1.37
Role of prostaglandin D2 in the hypothermia of rats caused by bacterial lipopolysaccharide. Proc Natl Acad Sci U S A (1982) 1.37
Successful pregnancy following blastocyst vitrification: case report. Hum Reprod (2000) 1.37
Regulation of adenylyl cyclase by protein kinase A. J Biol Chem (1995) 1.36
Effects of anesthesia and sleep on circulatory response to carotid sinus nerve stimulation. Am J Physiol (1971) 1.35
Structural similarities between the mammalian beta-adrenergic and reovirus type 3 receptors. Proc Natl Acad Sci U S A (1985) 1.34
CD1 expression in human atherosclerosis. A potential mechanism for T cell activation by foam cells. Am J Pathol (1999) 1.33
Three new regions on chromosome 17p13.3 distal to p53 with possible tumor suppressor gene involvement in lung cancer. Jpn J Cancer Res (2000) 1.32
Prostaglandin D2 induces sleep when microinjected into the preoptic area of conscious rats. Biochem Biophys Res Commun (1982) 1.31
Subcutaneous apomorphine in Parkinson's disease: response to chronic administration for up to five years. Mov Disord (1993) 1.30
Back extensor strength and lumbar spinal mobility are predictors of quality of life in patients with postmenopausal osteoporosis. Osteoporos Int (2007) 1.28
Sequence-based association analysis of HLA class I and II alleles in Japanese supports conservation of common haplotypes. Immunogenetics (1997) 1.28
Correlation between acute reductions in myocardial blood flow and function in conscious dogs. Circ Res (1980) 1.28
Apoptosis of cardiac myocytes in Gsalpha transgenic mice. Circ Res (1999) 1.28
Effects of hemorrhage on regional blood flow distribution in dogs and primates. J Clin Invest (1974) 1.27
Effects of propranolol on regional myocardial function, electrograms, and blood flow in conscious dogs with myocardial ischemia. J Clin Invest (1977) 1.27